Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4.
about
Insulin resistance in chronic kidney disease: a systematic review.A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease.Physical activity and metabolic health in chronic kidney disease: a cross-sectional study.Relationship between chronic kidney disease and metabolic syndrome: current perspectivesKidney function, β-cell function and glucose tolerance in older men.Nonesterified fatty acids and cardiovascular mortality in elderly men with CKDInsulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions.An overview of renal metabolomics.Role of Acid-Base Homeostasis in Diabetic Kidney Disease.Evaluation of Biochemical Markers Serum Amylase and Serum Lipase for the Assessment of Pancreatic Exocrine Function in Diabetes Mellitus.Insulin resistance in CKD.Risk of new-onset diabetes in end-stage renal disease patients undergoing dialysis: analysis from registry data of Taiwan.Insulin resistance in chronic kidney disease.ELABELA: a novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor.Chronic kidney disease promotes chronic inflammation in visceral white adipose tissue.C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care.A Systems-Level View of Renal Metabolomics.Helping Patients With ESRD and Earlier Stages of CKD to Quit Smoking.Reducing insulin resistance in patients undergoing peritoneal dialysis through the use of icodextrin-based solutions.Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
P2860
Q30244271-88A174FB-7686-4487-B3DD-62F34F3B2656Q30355733-6434BF1A-8C52-4BE0-9C03-F683F7ED9F1EQ30829502-817E90C5-DE58-4B79-A90A-967C1EB5C712Q34237672-ABFFD4FE-4C48-432E-B904-18C5C86DB48CQ35055095-1A72C375-1698-46C9-8643-FB1F947E27E1Q35278551-75BCD12F-8A6B-4098-BD8A-14FDE6453C8FQ38587721-0F517B33-1DC1-4E1B-A347-678902CE76E0Q38815775-4F0E4FDC-57A3-4BB9-BBE0-CBE141C55F6BQ38875980-80C328BA-E7D2-4BB2-A4A1-F72F6D7C241AQ40253215-B905EF06-0396-4EBC-B569-7E86EAC16A53Q42380185-63ED1BC8-56ED-4C56-9F51-F2BC945A2940Q47835929-337F1203-D6F1-43B4-A565-BBCAA764584CQ49859006-43E62144-A245-4BD6-9CDA-5E9089E210B7Q50662517-5E012E0A-AFFF-46D8-9D15-B73335E69124Q50946769-6D7EEB51-03E2-46C7-AB92-E2C1CFE4090CQ51723059-3E2B1024-1AB0-4180-B276-5339812A40E3Q52336692-E19FE139-7427-4FB1-8245-C175A893CDC9Q53409308-3EECFCD7-A5FE-40C9-A355-AA7320790BF2Q53832341-519FA3A2-0D1E-4E30-80B0-098B5F5672C5Q55424941-F9B0B329-6D07-4F18-ABD0-E9CDEF3506DF
P2860
Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical correlates of insulin ...... g men with CKD stages 3 and 4.
@en
Clinical correlates of insulin ...... g men with CKD stages 3 and 4.
@nl
type
label
Clinical correlates of insulin ...... g men with CKD stages 3 and 4.
@en
Clinical correlates of insulin ...... g men with CKD stages 3 and 4.
@nl
prefLabel
Clinical correlates of insulin ...... g men with CKD stages 3 and 4.
@en
Clinical correlates of insulin ...... g men with CKD stages 3 and 4.
@nl
P2860
P50
P356
P1476
Clinical correlates of insulin ...... ng men with CKD stages 3 and 4
@en
P2093
Tommy Cederholm
Ulf Risérus
P2860
P304
P356
10.2215/CJN.05230513
P577
2014-01-16T00:00:00Z